NCT07559669

Brief Summary

This study intends to use ultrasound to measure the bilateral diaphragmatic ultrasound indicators in critically ill patients, focusing on the left diaphragm, and to explore the consistency and reliability among various ultrasound indicators to evaluate the diaphragmatic mobility

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started May 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Dec 2026

First Submitted

Initial submission to the registry

April 12, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 30, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

May 5, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

April 12, 2026

Last Update Submit

April 23, 2026

Conditions

Keywords

Diaphragm ultrasoundcritical illness

Outcome Measures

Primary Outcomes (1)

  • Consistency of diaphragmatic mobility measurements between the standard and modified positions on the left side.

    The main purpose is to verify the consistency of the two methods, Measurements were performed after switching patients in the invasive group (intubated patients to T-piece oxygen at 5 L/min and tracheostomized patients to face mask oxygen at 5 L/min following weaning), and patients in the non-invasive group (those receiving non-invasive ventilation or high-flow oxygen therapy) to conventional face mask oxygen at 5 L/min.

    Measurements were performed 5 minutes after all patients were switched to conventional oxygen therapy at 5 L/min for the first time, once breathing had stabilized.

Secondary Outcomes (2)

  • Consistency of diaphragmatic excursion measurements between the standard position and the other four positions on the left side.

    Measurements were performed 5 minutes after all patients were switched to conventional oxygen therapy at 5 L/min for the first time, once breathing had stabilized.

  • Consistency of diaphragmatic excursion measurements between the standard position and the other five positions on the right side.

    Measurements were performed 5 minutes after all patients were switched to conventional oxygen therapy at 5 L/min for the first time, once breathing had stabilized.

Study Arms (2)

Invasive respiratory support group

The subjects of ultrasound measurement were patients with invasive mechanical ventilation

Noninvasive respiratory support group

The subjects of ultrasound measurement were patients with non-invasive respiratory support

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill patients

You may qualify if:

  • ①Adult patients (≥18 years old) of both sexes;
  • In invasive group, intubation or tracheotomy was changed to 5L/min T-tube or tracheotomy mask oxygen inhalation;
  • Patients in non-invasive group were treated with mask oxygen 5L/min;
  • agree to participate in the trial and sign the informed consent;

You may not qualify if:

  • ①The diaphragm ultrasound operation site was too large to obtain images.
  • Diaphragmatic ultrasound images could not be obtained in any section;
  • The ultrasound image quality of any section was poor;
  • the presence of phrenic nerve injury/paralysis ⑤ pregnant women; ⑥ Neuromuscular diseases such as ALS and myasthenia gravis affect the evaluation of spontaneous breathing ⑦ Patients deemed by the investigator to be ineligible.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2026

First Posted

April 30, 2026

Study Start

May 5, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04